SIRT6 Deficiency Culminates in Low-turnover Osteopenia

Overview

Journal Bone

Specialties Endocrinology
Orthopedics

Date 2015 Jul 21

PMID 26189760

Citations 25

Authors

Toshifumi Sugatani

Olga Agapova

Hartmut H Malluche

Keith A Hruska

Affiliations

Soon will be listed here.

Abstract

Deficiency of Sirtuin 6 (SIRT6), a chromatin-related deacetylase, in mice reveals severe premature aging phenotypes including osteopenia. However, the underlying molecular mechanisms of SIRT6 in bone metabolism are unknown. Here we show that SIRT6 deficiency in mice produces low-turnover osteopenia caused by impaired bone formation and bone resorption, which are mechanisms similar to those of age-related bone loss. Mechanistically, SIRT6 interacts with runt-related transcription factor 2 (Runx2) and osterix (Osx), which are the two key transcriptional regulators of osteoblastogenesis, and deacetylates histone H3 at Lysine 9 (H3K9) at their promoters. Hence, excessively elevated Runx2 and Osx in SIRT6(-/-) osteoblasts lead to impaired osteoblastogenesis. In addition, SIRT6 deficiency produces hyperacetylation of H3K9 in the promoter of dickkopf-related protein 1 (Dkk1), a potent negative regulator of osteoblastogenesis, and osteoprotegerin, an inhibitor of osteoclastogenesis. Therefore, the resulting up-regulation of Dkk1 and osteoprotegerin levels contribute to impaired bone remodeling, leading to osteopenia with a low bone turnover in SIRT6-deficient mice. These results establish a new link between SIRT6 and bone remodeling that positively regulates osteoblastogenesis and osteoclastogenesis.

Citing Articles

Role of sirtuins in obesity and osteoporosis: molecular mechanisms and therapeutic targets.

Du Y, Huo Y, Yang Y, Lin P, Liu W, Wang Z Cell Commun Signal. 2025; 23(1):20.

PMID: 39799353 PMC: 11724515. DOI: 10.1186/s12964-024-02025-7.

SIRT6 loss causes intervertebral disc degeneration in mice by promoting senescence and SASP status.

Ramteke P, Watson B, Toci M, Tran V, Johnston S, Tsingas M bioRxiv. 2024; .

PMID: 39314282 PMC: 11419082. DOI: 10.1101/2024.09.09.612072.

Research advances on silence information regulator 6 as a potential therapeutic target for bone regeneration and repair.

Pan W, He Y, Huang Y Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(4):427-433.

PMID: 39183069 PMC: 11375492. DOI: 10.3724/zdxbyxb-2023-0615.

Skeletal phenotypes and molecular mechanisms in aging mice.

Guan Q, Zhang Y, Wang Z, Liu X, Zou J, Zhang L Zool Res. 2024; 45(4):724-746.

PMID: 38894518 PMC: 11298674. DOI: 10.24272/j.issn.2095-8137.2023.397.

Unique quinoline orientations shape the modified aptamer to sclerostin for enhanced binding affinity and bone anabolic potential.

Gubu A, Ma Y, Yu S, Zhang H, Chen Z, Ni S Mol Ther Nucleic Acids. 2024; 35(1):102146.

PMID: 38444701 PMC: 10914587. DOI: 10.1016/j.omtn.2024.102146.

References

Long F . Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol. 2011; 13(1):27-38. DOI: 10.1038/nrm3254. View

Sugatani T, Vacher J, Hruska K . A microRNA expression signature of osteoclastogenesis. Blood. 2011; 117(13):3648-57. PMC: 3072882. DOI: 10.1182/blood-2010-10-311415. View

Yoshida C, Komori H, Maruyama Z, Miyazaki T, Kawasaki K, Furuichi T . SP7 inhibits osteoblast differentiation at a late stage in mice. PLoS One. 2012; 7(3):e32364. PMC: 3292551. DOI: 10.1371/journal.pone.0032364. View

Min L, Ji Y, Bakiri L, Qiu Z, Cen J, Chen X . Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat Cell Biol. 2012; 14(11):1203-11. DOI: 10.1038/ncb2590. View

Sundaresan N, Vasudevan P, Zhong L, Kim G, Samant S, Parekh V . The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun. Nat Med. 2012; 18(11):1643-50. PMC: 4401084. DOI: 10.1038/nm.2961. View

Baron R, Kneissel M . WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013; 19(2):179-92. DOI: 10.1038/nm.3074. View

Barbuto R, Mitchell J . Regulation of the osterix (Osx, Sp7) promoter by osterix and its inhibition by parathyroid hormone. J Mol Endocrinol. 2013; 51(1):99-108. PMC: 3685218. DOI: 10.1530/JME-12-0251. View

Piao J, Tsuji K, Ochi H, Iwata M, Koga D, Okawa A . Sirt6 regulates postnatal growth plate differentiation and proliferation via Ihh signaling. Sci Rep. 2013; 3:3022. PMC: 6505680. DOI: 10.1038/srep03022. View

Kugel S, Mostoslavsky R . Chromatin and beyond: the multitasking roles for SIRT6. Trends Biochem Sci. 2014; 39(2):72-81. PMC: 3912268. DOI: 10.1016/j.tibs.2013.12.002. View

10.

Crane J, Cao X . Function of matrix IGF-1 in coupling bone resorption and formation. J Mol Med (Berl). 2013; 92(2):107-15. PMC: 3946714. DOI: 10.1007/s00109-013-1084-3. View

11.

Guerrini M, Takayanagi H . The immune system, bone and RANKL. Arch Biochem Biophys. 2014; 561:118-23. DOI: 10.1016/j.abb.2014.06.003. View

12.

Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H . Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002; 3(6):889-901. DOI: 10.1016/s1534-5807(02)00369-6. View

13.

Zhang M, Xuan S, Bouxsein M, von Stechow D, Akeno N, Faugere M . Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem. 2002; 277(46):44005-12. DOI: 10.1074/jbc.M208265200. View

14.

Ashpole N, Sanders J, Hodges E, Yan H, Sonntag W . Growth hormone, insulin-like growth factor-1 and the aging brain. Exp Gerontol. 2014; 68:76-81. PMC: 4388761. DOI: 10.1016/j.exger.2014.10.002. View

15.

Mohan S, Richman C, Guo R, Amaar Y, Donahue L, Wergedal J . Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms. Endocrinology. 2003; 144(3):929-36. PMC: 2923925. DOI: 10.1210/en.2002-220948. View

16.

Fischle W, Wang Y, Allis C . Histone and chromatin cross-talk. Curr Opin Cell Biol. 2003; 15(2):172-83. DOI: 10.1016/s0955-0674(03)00013-9. View

17.

Malluche H, Sherman D, Meyer W, Massry S . A new semiautomatic method for quantitative static and dynamic bone histology. Calcif Tissue Int. 1982; 34(5):439-48. DOI: 10.1007/BF02411282. View

18.

Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C . Increased bone formation in osteocalcin-deficient mice. Nature. 1996; 382(6590):448-52. DOI: 10.1038/382448a0. View

19.

Sjogren K, Liu J, Blad K, Skrtic S, Vidal O, Wallenius V . Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A. 1999; 96(12):7088-92. PMC: 22065. DOI: 10.1073/pnas.96.12.7088. View

20.

Ross F, Teitelbaum S . alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology. Immunol Rev. 2005; 208:88-105. DOI: 10.1111/j.0105-2896.2005.00331.x. View